Design Cloud

  • Home

  • About Us

    Company Profile HIstory Culture Honor
    • Company Profile

    • HIstory

    • Culture

    • Honor

  • Products

    Cardiovascular series Psychiatry series Hepatobiliary, Gastroenterology Series Respiratory series Anti-infective virus series Other series Large Infusion Series Huabao Tong Series Active Pharmaceutical Ingredient Series
    • Cardiovascular series

    • Psychiatry series

    • Hepatobiliary, Gastroenterology Series

    • Respiratory series

    • Anti-infective virus series

    • Other series

    • Large Infusion Series

    • Huabao Tong Series

    • Active Pharmaceutical Ingredient Series

  • R&D

    Academician Expert Workstation Medical Research and Industry Alliance
    • Academician Expert Workstation

    • Medical Research and Industry Alliance

  • News

    General News Party group dynamics Employee activity
    • General News

    • Party group dynamics

    • Employee activity

  • HR

    Talent Strategy Company recruitment
    • Talent Strategy

    • Company recruitment

  • Contact us

  • 中文版

Image Name

News

  • Home page

General News

Party group dynamics

Employee activity

Environmental Announcement for Wanbangde Pharmaceutical Group's Annual Production Project of 2,195 Tons of Active Pharmaceutical Ingredients (including 12 products such as 600 tons/year of lipoic acid)

Date:

17 Jan,2023


Previous page

Industry-Education Integration and School-Enterprise Collaboration | Wanbangde Pharmaceutical Group Successfully Selected for the "2021–2022 Zhejiang Province Industry-Education Integrated Enterprise" List!

Honors | Wanbangde Pharmaceutical Group Named Among Top 500 High-Tech Enterprises in Zhejiang Province for Innovation Capability!

Next page

Related Recommendations

Image Name

2021/03/02

Traveling thousands of miles across provinces to pick you up! Wanbangde Pharmaceutical Group’s special shuttle bus returns to work, directly transporting employees back to their hometowns.

Image Name

2021/03/02

Environmental Impact Assessment Report for the 980-Ton Per Year Norfloxacin Production Technology Upgrade Project (Front-end Supplement) of Wanbangde Pharmaceutical Group Co., Ltd.

Image Name

2021/03/02

Lü Zhiliang, Minister of Organization and Standing Committee Member of the Taizhou Municipal Party Committee, visited Wanbangde Pharmaceutical Group to coordinate and address challenges hindering the company's development.

< 1...434445...78 > proceed page
  • Home

  • About Us

    • Company Profile

    • HIstory

    • Culture

    • Honor

  • Products

    • Cardiovascular series

    • Psychiatry series

    • Hepatobiliary, Gastroenterology Series

    • Respiratory series

    • Anti-infective virus series

    • Other series

    • Large Infusion Series

    • Huabao Tong Series

    • Active Pharmaceutical Ingredient Series

  • R&D

    • Academician Expert Workstation

    • Medical Research and Industry Alliance

  • News

    • General News

    • Party group dynamics

    • Employee activity

  • HR

    • Talent Strategy

    • Company recruitment

  • Contact us

  • 中文版

Image Name

Website Development: China Enterprise DynamicsTaizhou

Business license
浙ICP备10002622号-38